GENE ONLINE|News &
Opinion
Blog

R&D
A Global Perspective on Australia’s Biotechnology Industry: Key Insights Ahead of AusBiotech 2024
2024-10-22
Key Trends in the Pharmaceutical Pipeline for 2024 — Part I: Transformative R&D Growth Driven by Breakthroughs in Oncology, Neurological, and Metabolic Therapies
2024-10-18
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
BioAro’s PanOmiQ Tech Sets New Standard with 100% Accuracy in Whole Genome Sequencing
2024-08-23
J&J’s Q2 Increase: Cardiovascular Gains and Strategic Moves Amid Vaccine Decline
2024-08-06
LATEST
The Golden Age of Medicine: Advancements in Novel Modalities and Therapeutic Areas
2024-11-01
Strengthening Biotech Ties: Highlights from the BioConnect Forum and Future Collaboration between Taiwan and Australia
2024-10-31
AusBiotech 2024 Opening Ceremony: From Local to Global – Shaping the Future of Life Sciences and Biotech in Australia
2024-10-30
AMS BioteQ Showcases Game-Changing Innovations at Medical Japan 2024
2024-10-29
AusBiotech 2024 to Highlight Global Areas of Interest, Current Trends, and Research Directives in Australia’s Diverse Biotech Industry
2024-10-25
BPIPO and DCB Collaborate with NVIDIA to Host AI Forum, Focusing on Cross-Domain Integration for Precision Health
2024-10-25
CDMO Samsung Bio Secures Record $1.24 Billion Biopharma Manufacturing Contract, Raising Total 2024 Deal Value to Over $3.3 Billion
2024-10-23
EVENT
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top